Our results demonstrated that EP300-ZNF384 promotes B-ALL cell expansion by activating the expression of IL3Rα and the secretion of IL-3 at the initial stage of leukemogenesis. Here, IL3 is linked to precursor B-cell acute lymphoblastic leukemia.